| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.47 | 0.005 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |